| Drug repurposing: a promising tool to accelerate the drug discovery process V Parvathaneni, NS Kulkarni, A Muth, V Gupta Drug discovery today 24 (10), 2076-2085, 2019 | 352 | 2019 |
| Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer B Vaidya, V Parvathaneni, NS Kulkarni, SK Shukla, JK Damon, A Sarode, ... International journal of biological macromolecules 122, 338-347, 2019 | 107 | 2019 |
| Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ... International Journal of Biological Macromolecules 164, 638-650, 2020 | 70 | 2020 |
| Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ... International journal of pharmaceutics 577, 118995, 2020 | 61 | 2020 |
| Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ... Pharmaceutics 12 (3), 206, 2020 | 61 | 2020 |
| Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer SK Shukla, NS Kulkarni, A Chan, V Parvathaneni, P Farrales, A Muth, ... Pharmaceutics 11 (11), 559, 2019 | 60 | 2019 |
| Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ... Pharmaceutical research 37, 1-19, 2020 | 51 | 2020 |
| Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ... European Journal of Pharmaceutical Sciences 133, 145-159, 2019 | 51 | 2019 |
| Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis NS Kulkarni, Y Guererro, N Gupta, A Muth, V Gupta Journal of drug delivery science and technology 49, 352-364, 2019 | 50 | 2019 |
| Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ... Drug delivery and translational research 11, 927-943, 2021 | 47 | 2021 |
| Development of pharmaceutically scalable inhaled anti-cancer nanotherapy–repurposing amodiaquine for non-small cell lung cancer (NSCLC) V Parvathaneni, NS Kulkarni, G Chauhan, SK Shukla, R Elbatanony, ... Materials Science and Engineering: C 115, 111139, 2020 | 32 | 2020 |
| Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation SS Sawant, SM Patil, SK Shukla, NS Kulkarni, V Gupta, NK Kunda Drug Delivery and Translational Research, 1-14, 2022 | 21 | 2022 |
| Nanotechnology based repositioning of an anti-viral drug for non-small cell lung cancer (NSCLC) V Parvathaneni, M Goyal, NS Kulkarni, SK Shukla, V Gupta Pharmaceutical Research 37, 1-21, 2020 | 19 | 2020 |
| Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications NS Kulkarni, G Chauhan, M Goyal, S Sarvepalli, V Gupta Biomaterials Science 10 (16), 4492-4507, 2022 | 16 | 2022 |
| The preparation of lipid-based drug delivery system using melt extrusion G Chauhan, AA Shaik, NS Kulkarni, V Gupta Drug Discovery Today 25 (11), 1930-1943, 2020 | 16 | 2020 |
| Repurposing quinacrine for treatment of malignant mesothelioma: in-vitro therapeutic and mechanistic evaluation NS Kulkarni, B Vaidya, V Parvathaneni, D Bhanja, V Gupta International Journal of Molecular Sciences 21 (17), 6306, 2020 | 15 | 2020 |
| Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation–Evaluation of intestinal absorption and anti-cancer activity V Parvathaneni, RS Elbatanony, SK Shukla, NS Kulkarni, DD Kanabar, ... Journal of Molecular Liquids 327, 114866, 2021 | 14 | 2021 |
| Nano-synergistic combination of Erlotinib and Quinacrine for non-small cell lung cancer (NSCLC) therapeutics–Evaluation in biologically relevant in-vitro models NS Kulkarni, B Vaidya, V Gupta Materials Science and Engineering: C 121, 111891, 2021 | 10 | 2021 |
| Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles–Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment V Parvathaneni, SK Shukla, NS Kulkarni, V Gupta International Journal of Pharmaceutics 608, 121038, 2021 | 9 | 2021 |
| Therapeutic potential of inhalable medications to combat coronavirus disease-2019 V Parvathaneni, NS Kulkarni, A Muth, NK Kunda, V Gupta Therapeutic delivery 12 (2), 105-110, 2021 | 9 | 2021 |
Vivek Gupta, Ph.D.Associate Professor, Pharmaceutical Sciences, St. John's University College of PharmacyVerified email at stjohns.edu
